BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30400877)

  • 1. Cancer risk after renal transplantation in South Korea: a nationwide population-based study.
    Heo J; Noh OK; Oh YT; Chun M; Kim L
    BMC Nephrol; 2018 Nov; 19(1):311. PubMed ID: 30400877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancies after renal transplantation in Taiwan: a nationwide population-based study.
    Li WH; Chen YJ; Tseng WC; Lin MW; Chen TJ; Chu SY; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
    Nephrol Dial Transplant; 2012 Feb; 27(2):833-9. PubMed ID: 21633099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data.
    Park B; Yoon J; Choi D; Kim HJ; Jung YK; Kwon OJ; Lee KG
    Sci Rep; 2019 Nov; 9(1):17202. PubMed ID: 31748582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant malignancy: a burdensome complication in renal allograft recipients in Korea.
    Kim JH; Kim SO; Han DJ; Park SK
    Clin Transplant; 2014 Apr; 28(4):434-42. PubMed ID: 24750289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus-related anogenital premalignancies and cancer in renal transplant recipients: A Danish nationwide, registry-based cohort study.
    Reinholdt K; Thomsen LT; Dehlendorff C; Larsen HK; Sørensen SS; Haedersdal M; Kjaer SK
    Int J Cancer; 2020 May; 146(9):2413-2422. PubMed ID: 31291470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second primary cancer after liver transplantation in hepatocellular carcinoma: a nationwide population-based study.
    Heo J; Noh OK; Oh YT; Chun M; Kim L
    Hepatol Int; 2017 Nov; 11(6):523-528. PubMed ID: 28983776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of malignant neoplasms after liver transplantation: a population-based study.
    Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
    Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
    Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
    Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive therapy in the posttransplant period and skin cancer.
    Krásová M; Sečníková Z; Göpfertová D; Hercogová J; Viklický O; Jůzlová K; Jiráková A; Šmerhovský Z
    Dermatol Ther; 2016 Nov; 29(6):433-436. PubMed ID: 27328964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
    Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
    Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
    Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
    Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin cancer and (pre)malignancies of the female genital tract in renal transplant recipients.
    Meeuwis KA; van Rossum MM; van de Kerkhof PC; Hoitsma AJ; Massuger LF; de Hullu JA
    Transpl Int; 2010 Feb; 23(2):191-9. PubMed ID: 19793075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
    Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
    Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer incidence among Canadian kidney transplant recipients.
    Villeneuve PJ; Schaubel DE; Fenton SS; Shepherd FA; Jiang Y; Mao Y
    Am J Transplant; 2007 Apr; 7(4):941-8. PubMed ID: 17331115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy following renal transplantation.
    Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, risk factors and outcomes of malignancies after kidney transplantation in Singapore: a 12-year experience.
    Teo SH; Lee KG; Lim GH; Koo SX; Ramirez ME; Chow KY; Kee T
    Singapore Med J; 2019 May; 60(5):253-259. PubMed ID: 30311626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.